ShangHe Capital 16 portfolio companies were awarded as “Venture50 in 2022”

ShangHe Capital was awarded as “2022 China Influence Market-oriented Mother funds TOP10”

ShangHe Capital was awarded as “Top 20 Best Private and Market-oriented Fund of Funds in 2022”

ShangHe Capital 17 portfolio companies were awarded as “WISE King of New Economy in 2022”

5 Products from ShangHe Capital portfolio were awarded as “China Chip Superior Products”

ShangHe Capital 61 portfolio companies were awarded as “National-level Specialized New Giants”

ShangHe Capital was selected in two Top 10 lists by 36ker and FOFWEEKLY

ShangHe Capital was awarded as “Top 5 secondary fund Investment institutions in 2021-2022”

ShangHe Capital Portfolio companies was awarded as “Top 100 New brand in 2022”

ShangHe Capital Portfolio Bloomgae Biotech and MedBot was awarded as “Top 50 Smart Enterprise”

ShangHe Capital was awarded as “Top 20 best return Private and Market-orientend Fund of Fund in 2022”

ShangHe Capital Portfolio companies were awarded as “Top 500 Chinese New economy enterprises in 2021”

ShangHe Capital was selected into several industry lists

ShangHe Capital Founding Partner was awarded as “Top 40 best Young investors in 2022”

ShangHe Capital was awarded as “Top 20 Secoundary fund in 2021”

ShangHe Capital Founding Partner was awarded as “Top 10 Best female Successor Investors in fund of fund in 2022”

ShangHe Capital was awarded as “Top 10 Most socially responsible institutions in 2021”

ShangHe Capital was awarded as “Top 20 Best Private and Market-oriented Fund of Fund in 2021”

ShangHe Capital Founding Partner was awarded as “Top 30 young leaders of institutional LPs in 2021”

ShangHe Capital Founding Partner attended “The First Hainan Free Trade Port Global Venture Capital Forum”

ShangHe Capital was awarded as “Chinese Excellent and New investment institutions in 2020-2021”

ShangHe Capital was awarded as Zero2IPO Group “Top 10 Chinese fund secondary Investment institutions in 2021”

Shanghe Capital was awarded as FOF Research Institute“Top Upcoming Secondaries Fund in 2020-2021”; Ms Le Defang was awarded as FOF Research Institute “Top 40U40 Best FOF Investor in 2021”

Shanghe Capital was awarded as FOF Research Institute“Top10 Secondaries Fund with Potential in 2021”

Shanghe Capital was awarded “Top10 Emerging LPs in 2020”

Shanghe Capital accepted Family Offices interview

Ms. Le Defang，Managing partner of Shanghe Capital，was awarded as “Top 10 Best Female Secondaries Fund Managers in 2021”

Secondaries FOF Strategy for Family Offices

ShangHe Capital was awarded as LIE YUNWANG ‘2020 TOP 10 most potential secondary fund’

Ms. Le Defang, the managing partner of ShangHe Capital, was awarded as ‘TOP 30 LP young leaders of China Investment Institutions in 2020’

Welcome Le Defang

ShangHe Capital announces the closing of ‘S-FOF’ Fund I

Combating the 2019 Novel Coronavirus: The fifth batch of materials from ShangHe Capital has been successfully delivered to hospitals.

ShangHe Capital becomes a signatory to the UN-supported Principles for Responsible Investment (PRI).

ShangHe Capital's Managing Partner Mr. Qin Weijie makes commencement address at "the Creatives Entrepreneurs Program" at Tsinghua University.